CUTA

Across TCGA pan-cancer cohorts, CUTA mass-spec protein differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of CUTA’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where CUTA mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types CUTA is over-expressed in tumor, although a few such as HNSC and COAD show the opposite, repressed pattern.

HNSC, COAD, and LSCC are the cancer types where CUTA tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CUTA mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	Male	All	−0.610	<.001	11	view →
COAD	Male	III,IV	−0.481	<.001	11	view →
LSCC	Male	All	−0.263	<.001	7	view →
LUAD	All	All	−0.094	.001	4	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

CUTA–HNSC

Open the HNSC breakdown →